Repurposing related drug annotations

Provided are annotations for 6,125 drug and tool compounds (2,369 FDA-approved drugs, 1,619 drugs that reached phases 1-3 of clinical development, 96 compounds that were previously approved but withdrawn from use, and 2,041 preclinical or tool compounds). Annotations include compound name, chemical structure, clinical trial status, mechanism of action, protein targets, disease areas, approved indications (where applicable), purity of the purchased sample, and vendor ID.

本数据集提供了6,125种药物和工具化合物的标注信息（包括2,369种经美国食品药品监督管理局（FDA）批准的药物、1,619种处于1-3期临床试验阶段的药物、96种先前批准但已撤市的化合物以及2,041种临床前或工具化合物）。标注内容涵盖化合物名称、化学结构、临床试验状态、作用机制、蛋白靶点、疾病领域、批准适应症（如有）、购买样品的纯度以及供应商ID。